A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)
Status:
Completed
Trial end date:
2020-10-07
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety of two doses of gefapixant
(MK-7264) in Japanese adult participants with refractory or unexplained chronic cough.